Episode Details
Back to EpisodesEfficacy and Safety of Symbravo® in Participants with Migraine Experiencing an Inadequate Response to Oral CGRP Inhibitors
Published 4 months, 3 weeks ago
Description
Dr. Bradley Ong shares early insights from the EMERGE trial, presented at the American Headache Society’s 67th Annual Scientific Meeting in June 2025.
Show reference:
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14957